GPT and metabolic dysfunction-associated steatotic liver disease: A total number of 242 patients with diagnosed (with ultrasonography and/or AST and/or ALT level) NAFLD, aged 38–52 years, participated in these six interventions, and the mean number of randomized and analyzed patients per trial was 76 and 60, respectively.